United States · FDA National Drug Code directory
Erythromycin Ethylsuccinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60219-1504_0488543c-588b-4b75-acb3-4999aa84ebfc
- Product NDC
- 60219-1504
- Form
- SUSPENSION
- Composition / generic term
- Erythromycin
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231202
- Source listing expiry
- 20261231
Source-listed ingredients
- ERYTHROMYCIN ETHYLSUCCINATE — 400 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (60219-1504-2) · 60219-1504-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →